Profarma Distribuidora (Brazil) Performance
| PFRM3 Stock | BRL 6.09 0.18 2.87% |
Profarma Distribuidora has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of 0.51, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Profarma Distribuidora's returns are expected to increase less than the market. However, during the bear market, the loss of holding Profarma Distribuidora is expected to be smaller as well. Profarma Distribuidora right now holds a risk of 3.16%. Please check Profarma Distribuidora treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Profarma Distribuidora will be following its historical price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Profarma Distribuidora de are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Profarma Distribuidora may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
| Begin Period Cash Flow | 371.8 M | |
| Total Cashflows From Investing Activities | -86.4 M |
Profarma |
Profarma Distribuidora Relative Risk vs. Return Landscape
If you would invest 575.00 in Profarma Distribuidora de on October 25, 2024 and sell it today you would earn a total of 34.00 from holding Profarma Distribuidora de or generate 5.91% return on investment over 90 days. Profarma Distribuidora de is generating 0.1459% of daily returns and assumes 3.1607% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than Profarma, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Profarma Distribuidora Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Profarma Distribuidora's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Profarma Distribuidora de, and traders can use it to determine the average amount a Profarma Distribuidora's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0462
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | PFRM3 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.16 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Profarma Distribuidora is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Profarma Distribuidora by adding it to a well-diversified portfolio.
Profarma Distribuidora Fundamentals Growth
Profarma Stock prices reflect investors' perceptions of the future prospects and financial health of Profarma Distribuidora, and Profarma Distribuidora fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Profarma Stock performance.
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 122.61 M | |||
| Price To Earning | (6.45) X | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 6.41 B | |||
| EBITDA | 225.52 M | |||
| Cash And Equivalents | 139.49 M | |||
| Cash Per Share | 1.86 X | |||
| Total Debt | 740.04 M | |||
| Debt To Equity | 91.40 % | |||
| Book Value Per Share | 8.86 X | |||
| Cash Flow From Operations | 107.58 M | |||
| Earnings Per Share | 0.71 X | |||
| Total Asset | 4.03 B | |||
| Retained Earnings | 92 M | |||
| Current Asset | 1.57 B | |||
| Current Liabilities | 951 M | |||
About Profarma Distribuidora Performance
Assessing Profarma Distribuidora's fundamental ratios provides investors with valuable insights into Profarma Distribuidora's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Profarma Distribuidora is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.Things to note about Profarma Distribuidora performance evaluation
Checking the ongoing alerts about Profarma Distribuidora for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Profarma Distribuidora help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Profarma Distribuidora had very high historical volatility over the last 90 days | |
| Profarma Distribuidora has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 66.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Profarma Distribuidora's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Profarma Distribuidora's stock is overvalued or undervalued compared to its peers.
- Examining Profarma Distribuidora's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Profarma Distribuidora's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Profarma Distribuidora's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Profarma Distribuidora's stock. These opinions can provide insight into Profarma Distribuidora's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Profarma Stock Analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.